reference/1149371

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1149371

Outgoing Links

Predicate	Object
contentType	Journal Article\|Meta-Analysis\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
issn	1471-2407
issueIdentifier	1
pageRange	16-
publicationName	BMC Cancer
startingPage	16
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b533c627779eea61595a790292258b1f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7a24266ab9c1e893634f2e0c753beff1
bibliographicCitation	Thangapazham R, Saenz F, Katta S, Mohamed AA, Tan SH, Petrovics G, Srivastava S, Dobi A. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer. BMC Cancer. 2014 Jan 13;14():16. PMID: 24418414; PMCID: PMC3897978.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72963b5769cd340d3ef866fe0eca4072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_274e1e9365038acf36ec2e0ad902cf27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43196f0d7b94cf4f4946fa08f1f8fd7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5cbd31b1145ddf43f6642ab74c7859e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9d6609f79b7506f4e9cdbf88a034899 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fe8295f4635f61df45230b8228094b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_706c0ab623d855220db5603a5c27ae4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8250-7005 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec5de5d1c97a5fa75231ed49ae9d24df
date	2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/24418414 https://doi.org/10.1186/1471-2407-14-16 https://pubmed.ncbi.nlm.nih.gov/PMC3897978
isPartOf	https://portal.issn.org/resource/ISSN/1471-2407 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0471741 http://id.nlm.nih.gov/mesh/M0027627 http://id.nlm.nih.gov/mesh/M0504821 http://id.nlm.nih.gov/mesh/M0024955 http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0021788
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9a1fe2dcfa05760a672f7faf4c920042 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a23e3191f5240d877146769f040592e3 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7113 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4824 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2078

Total number of triples: 46.